Jun J Liu

6351283, Feb 26, 2002

Nov 27, 1996

08/755576

Jun Liu - Fremont CA

OmniVision Technologies, Inc. - Sunnyvale CA

H04N 5335

348301, 348302

An improved charge amplifier ( ) for use in a MOS imaging array is disclosed. The charge amplifier comprises a reference capacitor (C ), a sense capacitor (C ), an operational amplifier ( ), a first output capacitor (C ) connected to the output of the operational amplifier, a second output capacitor (C ) connected to the output of the operational amplifier, and a differential amplifier ( ) connected to the first output capacitor and said second output capacitor. In operation, the reference capacitor is charged to a reference voltage. Similarly, the sense capacitor is charged to a reference voltage. Both the sense capacitor and the reference capacitor are formed to be identical. However, the reference capacitor is covered from ambient light and the sense capacitor is exposed to ambient light. As ambient light is incident on the sense capacitor, the voltage carried by the sense capacitor diminishes. After a predetermined exposure time, both the voltage stored across the reference capacitor and the sense capacitor is amplified by the operational amplifier.

6875432, Apr 5, 2005

Oct 4, 2001

09/971511

Jun Liu - Pacifica CA, US
Steven J. Shire - Belmont CA, US

Genentech, Inc. - South San Francisco CA
Novartis AG - Basel

A61K038/16
A61K039/345
C07K014/00
C07K016/00

4241301, 4241331, 4241411, 4241431, 4241741, 4241761, 4241771, 514 2, 530350, 5303871, 5303873, 5303881, 53038822, 53038885, 5303897, 5303901, 5303905

The present application concerns concentrated protein formulations with reduced viscosity, which are particularly suitable for subcutaneous administration. The application further concerns a method for reducing the viscosity of concentrated protein formulations.

7552523, Jun 30, 2009

Jul 1, 2005

11/172778

Li He - Fremont CA, US
Jun Liu - San Ramon CA, US
Danning Yang - Fremont CA, US
Yining Hu - Fremont CA, US

Western Digital (Fremont), LLC - Fremont CA

G11B 5/127
H04R 31/00

2960316, 2960313, 2960314, 2960315, 2960318, 216 62, 216 66, 216 67, 360122, 360317, 451 5, 451 41

A method and system for manufacturing a perpendicular magnetic recording transducer by a process that includes plating is described. The method and system include forming a chemical mechanical planarization (CMP) uniformity structure around a perpendicular magnetic recording pole. The CMP uniformity structure has a height substantially equal to a desired pole height. The method and system also include fabricating an insulator on the CMP uniformity structure and performing a CMP to remove a portion of the insulator. The CMP exposes a portion of the perpendicular magnetic recording pole and planarizes an exposed surface of the perpendicular magnetic recording transducer.

7554767, Jun 30, 2009

Jul 1, 2005

11/172773

Yining Hu - Fremont CA, US
Jun Liu - San Ramon CA, US
Yingjian Chen - Fremont CA, US
Mark D. Thomas - Hollister CA, US
Kroum S. Stoev - Pleasanton CA, US

Western Digital (Fremont), LLC - Fremont CA

G11B 5/127
B24B 49/00

3601253, 451 5, 2960316

Methods are provided for fabricating an electrical lapping guide, and for using the electrical lapping guide to fabricate a transducer of a magnetic recording head. Additionally, transducers comprising an electrical lapping guide are also provided. Methods of fabricating the electrical lapping guide comprise forming a resistive element proximate to a shield pedestal. Accordingly, the resistive element is both aligned with the shield pedestal in a transverse direction, and closely spaced from the shield pedestal in a longitudinal direction. The resistance of the resistive element correlates well with a throat height of the shield pedestal, and the correlation is utilized in the methods of fabricating the transducer. When a magnetoresistive stripe is uses as a second electrical lapping guide while fabricating the transducer, the two can be used to control a tilt angle in the transverse direction during lapping.

7666413, Feb 23, 2010

Feb 28, 2005

11/068553

Jun Liu - Pacifica CA, US
Steven J. Shire - Belmont CA, US

Genetech, Inc. - South San Francisco CA
Novartis AG - Basel

A61K 39/395
C07K 16/00

4241301, 4241331, 4241441, 4241451, 4241771, 5303871, 5303873, 5303881, 53038825, 5303905

The present application concerns concentrated protein formulations with reduced viscosity, which are particularly suitable for subcutaneous administration. The application further concerns a method for reducing the viscosity of concentrated protein formulations.

8102162, Jan 24, 2012

Jun 11, 2009

12/482818

Zaki Moussaoui - San Carlos CA, US
Leigh Cormie - Mountain View CA, US
Jun Liu - San Jose CA, US

Intersil Americas Inc. - Milpitas CA

G05F 1/563

323266, 323222, 323271, 323285

An integrated circuit controller for controlling the operation of a voltage converter which includes a first comparator for comparing a voltage associated with an input of a boost converter with a threshold voltage and generating a control signal in response thereto. A second comparator compares a second voltage associated with an output of the boost converter with the threshold voltage and generates a second control signal in response thereto. Driver circuitry generates a first switching transistor drive signal and a second switching transistor drive signal. The first switching transistor drive signal is used for driving an upper gate switching transistor of a buck converter. The second switching transistor drive signal may be configured in a first mode of operation to drive a lower gate switching transistor of the buck converter and may be configured in a second mode of operation to drive a switching transistor of the boost converter. Control logic enables/disables at least a portion of the driver circuitry responsive to the control signal and the second control signal.

8142776, Mar 27, 2012

Dec 15, 2006

11/611751

Jun Liu - Pacifica CA, US
Steven J. Shire - Belmont CA, US

Genentech, Inc. - South San Francisco CA
Novartis AG - Basel

A61K 39/395

4241301, 4241331, 435800

The present application concerns concentrated protein formulations with reduced viscosity, which are particularly suitable for subcutaneous administration. The application further concerns a method for reducing the viscosity of concentrated protein formulations.

8372396, Feb 12, 2013

Sep 4, 2009

12/554194

James Andya - Millbrae CA, US
Shiang C. Gwee - Pacifica CA, US
Jun Liu - Pacifica CA, US
Ye Shen - San Francisco CA, US

Genetech, Inc. - South San Francisco CA

A61K 39/395

4241301, 4241331, 4241341

The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab).